- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01445652
A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients
September 11, 2013 updated by: CIBA VISION
The purpose of this study was to evaluate the relative benefits of daily disposable contact lenses versus spectacles in young adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Manchester, United Kingdom, M13 9PT
- Eurolens Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Understands rights as a research subject and willing and able to sign a Statement of Informed Consent, or if under 18, parent or guardian understands rights and is willing and able to sign a Statement of Informed Consent.
- Willing and able to follow the protocol.
- Currently wearing spectacles full-time (at least five days per week, eight hours per day).
- Has never worn contact lenses (more than one day) before.
- Agrees to not participate in other clinical research for the duration of this study.
- Can attain at least 6/9 in each eye with the study optical correction.
- Can be fitted with study lenses in the available power range (contact lens group) or can select a satisfactory spectacle lens frame and lenses (spectacle group).
- Willing and able to wear the study lenses or spectacles for a minimum of five days per week, eight hours per day.
- Owns or has regular access to a mobile phone and is familiar with SMS text messaging.
- Has an up-to-date and functional pair of spectacles at time of enrollment.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Has an ocular or systemic disorder that would normally contraindicate contact lens wear.
- Is using any topical medication such as eye drops or ointment.
- Has had corneal refractive surgery.
- Has had cataract surgery.
- Has diabetes.
- Has taken part in other clinical research within two weeks of starting the study.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: nelfilcon A
Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months
|
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Names:
|
Active Comparator: Spectacles
Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months
|
Spectacles per current prescription
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Happiness With Correction Type
Time Frame: Month 6
|
Participant responded to an SMS message: "Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good.
eg H2V4.
Please send N if in you are not wearing [contact lenses/spectacles]."
|
Month 6
|
Subjective Vision With Correction Type
Time Frame: Month 6
|
Participant responded to an SMS message: "Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good.
eg H2V4.
Please send N if in you are not wearing [contact lenses/spectacles]."
|
Month 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Philip Morgan, PhD MCOptom FAAO FBCLA, University of Manchester
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
September 30, 2011
First Submitted That Met QC Criteria
September 30, 2011
First Posted (Estimate)
October 4, 2011
Study Record Updates
Last Update Posted (Estimate)
September 19, 2013
Last Update Submitted That Met QC Criteria
September 11, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-370-C-091 / CB11-500
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on nelfilcon A contact lens
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Myopia | Ametropia
-
CIBA VISIONCompletedAstigmatism | Myopia
-
CIBA VISIONCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed